Sofwave™ Gains Additional U.S. Patent Protection For the Company’s Proprietary SUPERB™ Technology
July 05, 2023 08:30 ET
|
SofWave Medical, Ltd.
• The patent protects additional feature sets of SUPERB’s ultrasound and cooling technology • New patent win is the second U.S. technology patent earned in addition to previously issued IP in China,...
Sofwave Medical Reports First Quarter Fiscal 2023 Financial Results and Recent Business Highlights
May 10, 2023 08:30 ET
|
SofWave Medical, Ltd.
First Quarter Revenue of $10.4M, +86% Year-Over-Year Growth Over 125,000 Treatments Performed Since Initial Approval; Global Market Conditions Remain Favorable and Demand Continues to Grow in the...
Sofwave™ Wins Good Housekeeping Magazine Award for Best Anti-Aging Pro Treatment
May 02, 2023 08:30 ET
|
SofWave Medical, Ltd.
SAN CLEMENTE, Calif., May 02, 2023 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners...
Sofwave™ Wins 2023 NewBeauty Award For Best Non-Invasive Cellulite Treatment
March 30, 2023 08:30 ET
|
SofWave Medical, Ltd.
SAN CLEMENTE, Calif., March 30, 2023 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for...
Sofwave™ Granted FDA Clearance For Latest Innovation: The “Precise” SUPERB™ Applicator
March 15, 2023 10:18 ET
|
SofWave Medical, Ltd.
“Precise” delivers the same SUPERB™ technology in a compact applicator head for more convenient and precise treatment of smaller curved areas, such as around the eyes and mouthThe modular, smaller...
Sofwave Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights
March 08, 2023 08:30 ET
|
SofWave Medical, Ltd.
- Record Quarterly Revenue of $13.8M - Full Year Revenue Grew 63% YoY to $35.6M - Over 50,000 Pulse Treatments Conducted in 2022 - 2022 Recurring Revenue Up 177%, to $7.2M; Representing More...
Sofwave Medical to Participate in the Oppenheimer 33rd Annual Healthcare Conference
March 07, 2023 08:30 ET
|
SofWave Medical, Ltd.
SAN CLEMENTE, Calif., March 07, 2023 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide,...
Sofwave Gains Market Approval For SUPERB™ Non-Invasive Wrinkle Reduction and Lifting Technology in Mexico — the Second Largest Aesthetic Medical Market in Latin America
January 23, 2023 08:31 ET
|
SofWave Medical, Ltd.
SAN CLEMENTE, Calif., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced...
Sofwave Market Approvals For SUPERB™ Non-Invasive Wrinkle Reduction Technology Now Extend to Taiwan
December 21, 2022 08:30 ET
|
SofWave Medical, Ltd.
SAN CLEMENTE, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced...
Sofwave Medical Announces FDA Clearance of SUPERB™ Technology For Cellulite
December 19, 2022 08:30 ET
|
SofWave Medical, Ltd.
- The global cellulite treatment market in 2021* was valued at more than $1 billion, and expected to grow at a compound annual growth rate of 11% through 2030- Blinded reviewers correctly identified...